a number of biotech hedge funds are being forced to liquidate positions
Which ones?
There could be some funds shorting IDIX, given the recent news regarding their Hep-C program.
Now they want to develop an HIV nuke to compete with Sustiva. Good luck with that! Sustiva has been on the market for years, it's also one third of GILD's Truvada, the three in one pill.
Market Data 
Markets 
AI
